tegafur has been researched along with B16 Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, QD | 1 |
| Fan, H | 1 |
| Lou, WJ | 1 |
| Wang, QQ | 1 |
| Tang, GP | 1 |
| Kireev, GV | 1 |
| Navruzov, SN | 1 |
| Iusupova, AA | 1 |
| Akhunov, AA | 1 |
| Ibragimov, FA | 1 |
| Sadykov, AA | 1 |
| Tsukagoshi, S | 1 |
1 review available for tegafur and B16 Melanoma
| Article | Year |
|---|---|
[Fundamental studies on the surgical adjuvant chemotherapy to support the clinical efficacies].
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast N | 1997 |
2 other studies available for tegafur and B16 Melanoma
| Article | Year |
|---|---|
Polyethylenimine-cyclodextrin-tegafur conjugate shows anti-cancer activity and a potential for gene delivery.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; COS Cells; Cyclodextrins; DNA; Drug Combinations; | 2011 |
[Experimental investigation of the anticancer effects of soy proteins].
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Female; Melanoma, Experimental; Mice; Mice, Inbred | 2004 |